
PROJECTS


This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101194735. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe and Roboscreen.
The overall aim of VIROMARKERS is to define virus related biomarkers to improve management of chronic diseases, including biomarkers of response to antiviral treatment of persistent viral infections and virome features as indicators of disease progression in immunosuppressed people.
Validation or demonstration of the technologies required to measure the candidate biomarkers is an integral part of the project objectives. Indeed, certified lab systems are currently available only for a few of these items (e.g. HDV RNA) while others may obtain certification in the current year (e.g. total HIV DNA). Wherever necessary, the project includes all the preliminary lab activities to set up or refine investigational methods to measure the biomarker(s) considered.
Also, assay setup within VIROMARKERS generates the experimental data necessary to move prototype methods through the regulatory steps necessary to reach clinical application.
Indeed, the involvement of diagnostic companies into the project perfectly fits this need through sharing prior knowledge and expertise, supplying state-of-the-art reagents and equipment and filing for assay certification.
Work Packages Structure


Participants
-
EuResist Network (IT)
-
1 InformaPRO (IT)
-
-
Karolinska Institutet (SE)
-
Universita degli Studi di Siena (IT)
-
Klinikum der Universitaet zu Koeln (DE)
-
Paul-Ehrlich-Institut(DE)
-
Universita degli Studi di Roma Tor Vergata (IT)
-
Azienda Socio-Sanitaria Territoriale SS Paolo e Carlo (IT)
-
Heinrich-Heine-Universitaet Duesseldorf (DE)
-
European Liver Patients Association (BE)
-
European Aids Treatment Group (DE)
-
University College London (UK)
-
Ospedale Maggiore Policlinico Milano (IT)
-
MIB Dienstleistung (DE)
-
altona diagnostics (DE)
-
Roboscreen (DE)
-
Diatheva (IT)
-
Societa Italiana Articoli di Laboratorio (IT)
-
A. Menarini Diagnostics (IT)
-
Qiagen (DE)
Start date: 01 February 2025
End date: 31 January 2028
Total cost: 4 358 845.00€
Grant amount: 2.329.503,75€


Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.